Progress data according to Symptoms
Yes |
964 |
70.51% |
Improved |
860 |
89.21% |
Not respond |
104 |
10.78% |
No |
403 |
29.48% |
Yes |
970 |
70.95% |
Improved |
878 |
90.51% |
Not respond |
92 |
9.48% |
No |
397 |
29.04% |
Normal |
187 |
13.67% |
Less |
295 |
21.58% |
Improved |
211 |
71.52% |
Not respond |
84 |
28.47% |
Increased |
885 |
64.74% |
Improved |
601 |
67.90% |
Not respond |
284 |
32.09% |
Normal |
815 |
59.60% |
Poor |
552 |
40.38% |
Improved |
316 |
52.24% |
Not respond |
236 |
42.75% |
Yes |
1097 |
80.24% |
Chronic |
197 |
17.95% |
Improved |
72 |
36.54% |
Not respond |
125 |
63.95% |
Moderate |
415 |
37.83% |
Improved |
220 |
53.01% |
Not respond |
195 |
46.98% |
Mild |
485 |
37.83% |
Improved |
331 |
68.24% |
Not respond |
154 |
31.75% |
No |
270 |
19.75% |
Yes |
1127 |
82.44% |
Improved |
755 |
66.99% |
0-2 Kg |
174 |
23.04% |
2-4 Kg |
483 |
63.97% |
4-8 Kg |
98 |
12.98% |
Stable |
372 |
33% |
No |
240 |
17.55% |
Yes |
1185 |
86.68% |
Acute |
216 |
18.22% |
Improved |
93 |
43.05% |
Not respond |
123 |
56.94% |
Moderate |
530 |
44.72% |
Improved |
357 |
67.35% |
Not respond |
173 |
32.64% |
Mild |
439 |
37.04% |
Improved |
358 |
81.54% |
Not respond |
81 |
18.45% |
No |
182 |
13.31% |
Yes |
1233 |
90.19% |
Acute |
216 |
17.51% |
Improved |
187 |
86.57% |
Not respond |
483 |
63.97% |
Moderate |
578 |
46.87% |
Improved |
489 |
84.6% |
Not respond |
89 |
15.39% |
Mild |
439 |
17.51% |
Improved |
385 |
87.69% |
Not respond |
54 |
12.30% |
No |
134 |
9.80% |
Yes |
370 |
27.06% |
No |
997 |
72.93% |
Regular |
27 |
7.29% |
Improved |
4 |
14.81% |
Not respond |
23 |
85.18% |
Often |
343 |
92.70% |
Improved |
163 |
47.52% |
Not respond |
180 |
52.47% |
Yes |
223 |
16.31% |
Acute |
103 |
46.18% |
Improved |
37 |
35.92% |
Not respond |
66 |
64.07% |
Chronic |
120 |
53.81% |
Improved |
34 |
28.33% |
Not respond |
86 |
71.66% |
No |
1144 |
64.07% |
Yes |
960 |
70.22% |
Regular |
97 |
10.10% |
Improved |
2 |
18.18% |
Not respond |
9 |
81.81% |
Moderate |
29 |
29.89% |
Improved |
19 |
65.51% |
Not respond |
10 |
34.48% |
Mild |
57 |
58.76% |
Improved |
40 |
70.17% |
Not respond |
17 |
29.82% |
Often |
863 |
89.89% |
Acute |
204 |
23.63% |
Improved |
116 |
18.18% |
Not respond |
88 |
81.81% |
Moderate |
585 |
67.78% |
Improved |
389 |
68.03% |
Not respond |
187 |
31.96% |
Mild |
74 |
8.57% |
Improved |
53 |
71.62% |
Not respond |
21 |
28.37% |
No |
407 |
29.77% |
Yes |
555 |
40.59% |
Regular |
32 |
5.76% |
Severe |
7 |
21.87% |
Improved |
2 |
28.57% |
Not respond |
5 |
71.42% |
Moderate |
15 |
46.87% |
Improved |
4 |
26.66% |
Not respond |
11 |
73.33% |
Mild |
10 |
31.25% |
Improved |
5 |
50.00% |
Not respond |
5 |
50.00% |
Often/on Climbing |
523 |
94.23% |
Severe |
300 |
57.36% |
Improved |
188 |
39.33% |
Not respond |
182 |
60.66% |
Moderate |
146 |
27.91% |
Improved |
68 |
46.57% |
Not respond |
78 |
53.42% |
Mild |
77 |
14.72% |
Improved |
44 |
57.14% |
Not respond |
33 |
42.85% |
No |
812 |
59.40% |
Yes |
1069 |
78.20% |
Acute |
135 |
12.62% |
Improved |
50 |
37.03% |
Not respond |
85 |
62.96% |
Moderate |
620 |
57.99% |
Improved |
366 |
59.03% |
Not respond |
254 |
40.96% |
Mild |
313 |
29.27% |
Improved |
212 |
67.73% |
Not respond |
101 |
32.26% |
No |
298 |
21.79% |
Yes |
1042 |
76.22% |
Acute |
186 |
17.85% |
Improved |
50 |
26.88% |
Not respond |
136 |
73.11% |
Mild |
252 |
24.18% |
Improved |
174 |
69.04% |
Not respond |
78 |
30.95% |
Moderate |
604 |
57.96% |
Improved |
383 |
63.41% |
Not respond |
221 |
36.58% |
No |
325 |
23.77% |
Yes |
942 |
68.91% |
Acute |
104 |
|
Improved |
14 |
13.46% |
Not respond |
90 |
86.53% |
Moderate |
254 |
|
Improved |
118 |
46.45% |
Not respond |
136 |
53.54% |
Mild |
584 |
|
Improved |
398 |
68.15% |
Not respond |
186 |
31.84% |
No |
425 |
31.08% |
Yes |
823 |
60.20% |
Acute |
104 |
|
Improved |
18 |
17.30% |
Not respond |
86 |
82.69% |
Moderate |
384 |
|
Improved |
130 |
33.85% |
Not respond |
254 |
66.14% |
Mild |
335 |
|
Improved |
224 |
66.86% |
Not respond |
111 |
31.13% |
No |
544 |
39.79% |
Yes |
1069 |
78.20% |
Acute |
167 |
15.62% |
Improved |
69 |
41.31% |
Not respond |
98 |
58.68% |
Moderate |
523 |
48.92% |
Improved |
344 |
65.77% |
Not respond |
179 |
34.22% |
Mild |
379 |
35.45% |
Improved |
296 |
78.10% |
Not respond |
83 |
21.89% |
No |
298 |
21.79% |
Yes |
992 |
72.56% |
Excessive |
72 |
7.25% |
Improved |
27 |
37.50% |
Not respond |
45 |
62.50% |
Moderate |
504 |
50.80% |
Improved |
272 |
53.96% |
Not respond |
232 |
46.03% |
Mild |
416 |
41.93% |
Improved |
280 |
67.30% |
Not respond |
136 |
32.69% |
No |
375 |
27.43% |
Yes |
344 |
25.16% |
Acute |
56 |
16.27% |
Improved |
12 |
21.42% |
Not respond |
44 |
78.57% |
Moderate |
127 |
36.91% |
Improved |
51 |
40.15% |
Not respond |
76 |
59.84% |
Mild |
161 |
46.80% |
Improved |
90 |
55.90% |
Not respond |
71 |
44.09% |
No |
1023 |
74.83% |
Yes |
473 |
34.60% |
Acute |
39 |
8.24% |
Improved |
6 |
15.38% |
Not respond |
33 |
84.62% |
Moderate |
171 |
36.15% |
Improved |
70 |
40.93% |
Not respond |
101 |
59.06% |
Mild |
263 |
55.60% |
Improved |
168 |
63.87% |
Not respond |
95 |
36.12% |
No |
894 |
65.39% |
Yes |
988 |
72.27% |
Regular |
268 |
27.12% |
Improved |
183 |
68.28% |
Not respond |
85 |
31.71% |
Irregular |
720 |
72.87% |
Improved |
518 |
71.94% |
Not respond |
202 |
28.05% |
No |
379 |
27.72% |
Yes |
88 |
6.43% |
Improved |
24 |
27.27% |
Not respond |
64 |
72.27% |
Irregular |
1279 |
93.56% |
Yes |
434 |
46.17% |
Acute |
107 |
24.65% |
Improved |
107 |
100% |
Not respond |
0 |
0% |
Chronic |
327 |
75.34% |
Improved |
284 |
87.00% |
Not respond |
43 |
13.00% |
No |
506 |
53.82% |
Yes |
284 |
66.51% |
Acute |
78 |
27.46% |
Improved |
78 |
100% |
Not respond |
0 |
0% |
Chronic |
206 |
72.53% |
Improved |
175 |
85.00% |
Not respond |
31 |
15.00% |
No |
143 |
33.48% |
Progress data according to General information
Progress data according to Pathological reports (Biochemical tests)